{
  "id": 19140563,
  "title": "BioNTech vs. Moderna: The COVID Vaccine Giants Are Entering a New Era. One Stock Could Have the Edge for 2027",
  "url": "https://urgent.news/2026/11/09/biontech-vs-moderna-the-covid-vaccine-giants-are-entering-a-new-era-19140563",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-09T10:20:02.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/biontech-vs-moderna-covid-vaccine-giants-are-entering-new-era-one-stock-could-have-edge"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsBioNTech and Moderna are working to reduce their dependence on COVID-19 vaccines through expanding pipelines in cancer treatment and other diseases.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "BioNTech vs. Moderna: The COVID Vaccine Giants Are Entering a New Era. One Stock Could Have the Edge for 2027",
        "url": "https://urgent.news/2026/11/09/biontech-vs-moderna-the-covid-vaccine-giants-are-entering-a-new-era",
        "published": "2026-11-09T10:00:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}